Paul Helft, MD, discusses the case of a 62-year-old male patient with newly diagnosed stage IV colorectal cancer with a KRAS mutation.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
![](https://i.ytimg.com/vi/JjtJDmiha0A/maxresdefault.jpg)
Paul Helft, MD, discusses the case of a 62-year-old male patient with newly diagnosed stage IV colorectal cancer with a KRAS mutation.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]